Efficient is a dynamic, multifaceted, forward-thinking developer of continuing medical education (CME). The organization was created in response to its belief that many CME activities are underutilized or poorly attended because quite simply they are not efficient and do not align with the needs, professional demands, and lifestyles of practicing clinicians.

Efficient aspires to use its expertise in instructional design to create a variety of accredited live and enduring resources that will increase engagement and facilitate the application of new information by the physicians and other healthcare professionals that access them.

Through our partnership with CME Outfitters, CME/CE accreditations for the activities include AMA PRA Category 1 Credits™, ANCC (nursing), AAPA (physician associates), ACPE (pharmacy), APA (psychology), American Board of Internal Medicine Maintenance of Certification, as well as others.

To participate, click on an activity title or the Begin Now button to read details on the activity and to participate. You will be asked to create a free account to participate in the activities. This free account will serve as a personalized learning catalogue where you can see a list of activities started and completed as well as access all CME/CE certificates earned.

Unveiling HER2-Low and Ultralow Expression in mBC: Implications for the Multidisciplinary Care Team

In the first activity of this EfficientCME webcast series, two leading breast oncologists and a partnering pathologist examine the evolving understanding of HER2 biology and explain why new testing and interpretation methods for HER2-low and ultralow expression in mBC are emerging. Through expert discussion, they explore key evidence driving this shift and what it means for clinical practice moving forward.

BEGIN NOW

What’s Your Protocol? Streamlining Oncology/Pathology Collaboration Throughout the BC Journey

In the second activity of this EfficientCME webcast series, oncologist-pathologist faculty pairs present real-world examples from their own institutions that highlight how to apply current HER2 immunohistochemistry scoring guidelines and incorporate emerging assays into routine practice. Learners will discover strategies to strengthen communication and decision-making across the multidisciplinary care team, ensuring more accurate reporting, efficient treatment planning, and ultimately, better outcomes for patients living with mBC.

BEGIN NOW

Methodologies for HER2-Low and Ultralow IHC: A Guided Laboratory Case Walk-through for Pathologists

In the third activity of this EfficientCME webcast series, faculty guide learners through a step-by-step case discussion that mirrors real-world practice. Faculty demonstrate how to apply the latest IHC scoring strategies to distinguish HER2-low and ultralow disease, and model best practices for reporting results in ways that directly support therapeutic decision-making.

BEGIN NOW